Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2

We present a case of symptomatic heterotopic bone formation following revision of posterolateral lumbar fusion/instrumentation and “off-label” use of recombinant human bone morphogenetic protein-2, treated successfully with the use of a minimally invasive tubular approach.

Detalles Bibliográficos
Autores principales: Roberti, Fabio, Arsenault, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202823/
https://www.ncbi.nlm.nih.gov/pubmed/32387785
http://dx.doi.org/10.1016/j.wneu.2020.04.235
_version_ 1783529768961966080
author Roberti, Fabio
Arsenault, Katie
author_facet Roberti, Fabio
Arsenault, Katie
author_sort Roberti, Fabio
collection PubMed
description We present a case of symptomatic heterotopic bone formation following revision of posterolateral lumbar fusion/instrumentation and “off-label” use of recombinant human bone morphogenetic protein-2, treated successfully with the use of a minimally invasive tubular approach.
format Online
Article
Text
id pubmed-7202823
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72028232020-05-07 Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2 Roberti, Fabio Arsenault, Katie World Neurosurg Technical Note We present a case of symptomatic heterotopic bone formation following revision of posterolateral lumbar fusion/instrumentation and “off-label” use of recombinant human bone morphogenetic protein-2, treated successfully with the use of a minimally invasive tubular approach. Elsevier Inc. 2020-09 2020-05-06 /pmc/articles/PMC7202823/ /pubmed/32387785 http://dx.doi.org/10.1016/j.wneu.2020.04.235 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Technical Note
Roberti, Fabio
Arsenault, Katie
Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
title Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
title_full Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
title_fullStr Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
title_full_unstemmed Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
title_short Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
title_sort minimally invasive lumbar decompression and removal of symptomatic heterotopic bone formation after spinal fusion with recombinant human bone morphogenetic protein-2
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202823/
https://www.ncbi.nlm.nih.gov/pubmed/32387785
http://dx.doi.org/10.1016/j.wneu.2020.04.235
work_keys_str_mv AT robertifabio minimallyinvasivelumbardecompressionandremovalofsymptomaticheterotopicboneformationafterspinalfusionwithrecombinanthumanbonemorphogeneticprotein2
AT arsenaultkatie minimallyinvasivelumbardecompressionandremovalofsymptomaticheterotopicboneformationafterspinalfusionwithrecombinanthumanbonemorphogeneticprotein2

Ejemplares similares